Financhill
Back

Harvard Bioscience Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
43

HBIO
Harvard Bioscience

Last Price:
2.37
Seasonality Move:
6.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Harvard Bioscience Price Quote

$2.37
+0.01 (+-1.25%)
(Updated: November 5, 2024 at 5:27 AM ET)

Harvard Bioscience Key Stats

Sell
43
Harvard Bioscience (HBIO) is a Sell

Day range:
$2.35 - $2.43
52-week range:
$2.30 - $5.56
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.00
P/B ratio:
1.53%

Volume:
64.7K
Avg. volume:
114.5K
1-year change:
-45.12%
Market cap:
$102.9M
Revenue:
$112.3M
EPS:
$-0.25

How Much Does Harvard Bioscience Make?

Is Harvard Bioscience Growing As A Company?

  • What Is Harvard Bioscience's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.2%
  • What Is Harvard Bioscience's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Harvard Bioscience Stock Price Performance

What Is Harvard Bioscience 52-Week High & Low?

Harvard Bioscience Price To Free Cash Flow

Is It Risky To Buy Harvard Bioscience?

Is Harvard Bioscience Cash Flow Positive?

  • What Is HBIO Cash Flow From Operations?
    Cash flow from operations (TTM) is $9.2M
  • What Is Harvard Bioscience’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$7.7M
  • What Is Harvard Bioscience’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.2M

Harvard Bioscience Return On Invested Capital

  • Is Management Doing A Good Job?
    HBIO return on invested capital is -9.76%
  • What Is Harvard Bioscience Return On Assets?
    ROA measures how assets are converting to revenues and is -7.83%
  • What Is HBIO Return On Equity?
    ROE is a measure of profitability and is -14.88%

Harvard Bioscience Earnings Date & Stock Price

Harvard Bioscience Competitors

Harvard Bioscience Dividend Yield

Harvard Bioscience Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -100%
Revenue: -19.69% -12.51%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.25
Upside from Last Price: 164.83%

Major Shareholders

  • How many HBIO shares are owned by institutional investors?
    45.6M HBIO shares are owned by institutional investors
  • How many HBIO shares are owned by insiders?
    11.9M HBIO shares are owned by insiders